DE60038099D1 - Neisseria impfstoffzusammensetzungen und methoden - Google Patents

Neisseria impfstoffzusammensetzungen und methoden

Info

Publication number
DE60038099D1
DE60038099D1 DE60038099T DE60038099T DE60038099D1 DE 60038099 D1 DE60038099 D1 DE 60038099D1 DE 60038099 T DE60038099 T DE 60038099T DE 60038099 T DE60038099 T DE 60038099T DE 60038099 D1 DE60038099 D1 DE 60038099D1
Authority
DE
Germany
Prior art keywords
methods
neisseria
compositions
vaccine compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60038099T
Other languages
English (en)
Other versions
DE60038099T2 (de
Inventor
Andrew Robinson
Andrew Richard Gorringe
Michael John Hudson
Philippa Bracegirdle
John Simon Kroll
Keith Cartwright
Steven Webb
Paul Richard Langford
Cliona Anne O'dwyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Protection Agency
Ip2ipo Innovations Ltd
Original Assignee
Health Protection Agency
Imperial Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9904028.9A external-priority patent/GB9904028D0/en
Priority claimed from GBGB9922561.7A external-priority patent/GB9922561D0/en
Application filed by Health Protection Agency, Imperial Innovations Ltd filed Critical Health Protection Agency
Publication of DE60038099D1 publication Critical patent/DE60038099D1/de
Application granted granted Critical
Publication of DE60038099T2 publication Critical patent/DE60038099T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60038099T 1999-02-22 2000-02-22 Neisseria impfstoffzusammensetzungen und methoden Expired - Lifetime DE60038099T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9904028 1999-02-22
GBGB9904028.9A GB9904028D0 (en) 1999-02-22 1999-02-22 Neisserial vaccine
GB9922561 1999-09-23
GBGB9922561.7A GB9922561D0 (en) 1999-09-23 1999-09-23 Neisserial vaccine compositions and methods
PCT/GB2000/000624 WO2000050074A2 (en) 1999-02-22 2000-02-22 Neisserial vaccine compositions and methods

Publications (2)

Publication Number Publication Date
DE60038099D1 true DE60038099D1 (de) 2008-04-03
DE60038099T2 DE60038099T2 (de) 2009-02-19

Family

ID=26315168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60038099T Expired - Lifetime DE60038099T2 (de) 1999-02-22 2000-02-22 Neisseria impfstoffzusammensetzungen und methoden

Country Status (12)

Country Link
US (1) US7157245B2 (de)
EP (2) EP1154791B1 (de)
JP (1) JP4982009B2 (de)
AT (1) ATE386541T1 (de)
AU (1) AU779086B2 (de)
CA (1) CA2371928C (de)
CY (1) CY1107950T1 (de)
DE (1) DE60038099T2 (de)
DK (1) DK1154791T3 (de)
ES (1) ES2298128T3 (de)
PT (1) PT1154791E (de)
WO (1) WO2000050074A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081244B2 (en) * 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
EP1374892A1 (de) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Arzneimittel zur Behandlung von infektiösen Krankheiten infolge Neisseria Meningitidis
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
EP1654364A4 (de) * 2003-08-13 2008-02-13 Novartis Vaccines & Diagnostic Zuführung von immungene codierenden polynukleotiden an inakivierte wirtszellen
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
RU2477145C2 (ru) 2008-05-30 2013-03-10 ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB0922224D0 (en) 2009-12-21 2010-02-03 Hiltech Developments Ltd Transformation of commensal neisseria
US10286016B2 (en) 2014-09-02 2019-05-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating gonorrhea
US10900043B2 (en) 2014-09-02 2021-01-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating bacterial disease
GB201522153D0 (en) * 2015-12-15 2016-01-27 Univ Southampton Meningococcal infection and modified neisseria lactamica
US12005110B2 (en) 2019-02-14 2024-06-11 University Of Florida Research Foundation, Incorporated Honeybee commensal Snodgrassella alvi vaccine against pathogenic Neisseriaceae

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288617A (en) 1984-10-31 1994-02-22 Commonwealth Scientific And Industrial Research Organization Method of producing an antigenic preparation
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5470740A (en) * 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
IL117483A (en) * 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
US20030215469A1 (en) * 1998-11-02 2003-11-20 Microbiological Research Authority Multicomponent meningococcal vaccine
GB9823978D0 (en) * 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
US6703233B1 (en) * 1998-12-02 2004-03-09 University Of Maryland, Baltimore Plasmid maintenance system for antigen delivery
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
US7081244B2 (en) * 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation

Also Published As

Publication number Publication date
WO2000050074A3 (en) 2000-12-28
EP1154791A2 (de) 2001-11-21
US20030026809A1 (en) 2003-02-06
ES2298128T3 (es) 2008-05-16
CA2371928A1 (en) 2000-08-31
PT1154791E (pt) 2008-05-30
EP1154791B1 (de) 2008-02-20
AU2681100A (en) 2000-09-14
CY1107950T1 (el) 2013-09-04
JP4982009B2 (ja) 2012-07-25
ATE386541T1 (de) 2008-03-15
WO2000050074A2 (en) 2000-08-31
EP1852125A2 (de) 2007-11-07
AU779086B2 (en) 2005-01-06
CA2371928C (en) 2013-08-13
DE60038099T2 (de) 2009-02-19
DK1154791T3 (da) 2008-06-16
JP2002537352A (ja) 2002-11-05
EP1852125A3 (de) 2010-09-22
US7157245B2 (en) 2007-01-02

Similar Documents

Publication Publication Date Title
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
CY1110880T1 (el) Αντιγονα neisserial
GB0103424D0 (en) Gonococcus proteins
DK1047784T3 (da) Neissera meningitidis-antigener
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
WO1998056901A3 (en) Live attenuated vaccines
MY125202A (en) Vaccine
HUP0100623A2 (hu) Eljárások bakteriális burok-poliszacharidok extrakciójára és izolálására, azok vakcinaként vagy fehérjékhez kapcsoltan konjugátum-vakcinaként történő alkalmazására
WO2002075507A3 (en) Anti-bacterial vaccine compositions
WO2002034773A3 (en) Streptococcal genes
WO2000061724A3 (en) Anti-bacterial vaccine compositions
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
NO20013101L (no) Ytre overflateproteiner, deres gener og deres anvendelse
AU2001258579A1 (en) Virulence genes, proteins, and their use

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: ROBINSON, ANDREW, SALISBURY, WILTSHIRE SP4 0JG, GB

Inventor name: GORRINGE, ANDREW RICHARD, SALISBURY, WILTSHIRE, GB

Inventor name: HUDSON, MICHAEL JOHN, SALISBURY, WILTSHIRE SP4, GB

Inventor name: BRACEGIRDLE, PHILIPPA, SALISBURY, WILTSHIRE SP, GB

Inventor name: KROLL, JOHN SIMON, LONDON W2 1PG, GB

Inventor name: CARTWRIGHT, KEITH, LONDON NW9 5DF, GB

Inventor name: WEBB, STEVEN,ANTHONY,ROCHFORD, SUBIACO, WESTER, AU

Inventor name: LANGFORD, PAUL RICHARD, OXFORD OX1 4PT, GB

Inventor name: O'DWYER CLIONA ANNE, COUNTRY GALWAY, IE

8364 No opposition during term of opposition